fda deadline for semaglutide shortage status january 2025 As of February 21, 2025, the updated its drug list FDA Approves Wegovy Weight-Loss Pill

Wegovy is specifically FDA-approved for chronic weight management, whereas metformin is primarily for blood sugar control

Indigestion or acid reflux: This may feel like burning in the throat, chest, or upper abdomen

In pre-clinical studies, GLP-1 mediated delivery of estrogen or dexamethasone has proven beneficial effects on glucose tolerance, bodyweight control and systemic inflammation (81)

It's worth considering as part of a broader musculoskeletal protection plan during GLP-1 therapy - after a provider conversation and with realistic expectations about what a dietary supplement can and cannot do

Even more concerning are drugs that are still in clinical trials (like retatrutide, cagrilintide, and others) being sold directly to consumers